- Home
- ASST vs PACB Comparison
ASST vs PACB Comparison
Compare ASST & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASST | PACB |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 636.4M | 555.5M |
| IPO Year | 2023 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ASST | PACB |
|---|---|---|
| Price | $1.04 | $2.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $1.50 | ★ $2.08 |
| AVG Volume (30 Days) | ★ 75.2M | 6.3M |
| Earning Date | 11-14-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,512,106.00 | ★ $154,584,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $11.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 125.01 | N/A |
| 52 Week Low | $0.73 | $0.85 |
| 52 Week High | $7.89 | $2.73 |
Technical Indicators
Market Signals| Indicator | ASST | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 55.14 |
| Support Level | $0.73 | $1.67 |
| Resistance Level | $0.87 | $1.89 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 84.76 | 89.25 |
Price Performance
Historical ComparisonAbout ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.